Is deep brain stimulation neuroprotective if applied early in the course of PD?
- PMID: 18594505
- DOI: 10.1038/ncpneuro0848
Is deep brain stimulation neuroprotective if applied early in the course of PD?
Similar articles
-
Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return?Arch Neurol. 2005 Apr;62(4):533-6. doi: 10.1001/archneur.62.4.533. Arch Neurol. 2005. PMID: 15824249 No abstract available.
-
Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion.Exp Neurol. 2008 Jun;211(2):321-3. doi: 10.1016/j.expneurol.2008.02.021. Epub 2008 Mar 7. Exp Neurol. 2008. PMID: 18410927 Review. No abstract available.
-
Contrast sensitivity in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.Mov Disord. 2009 Apr 15;24(5):766-9. doi: 10.1002/mds.22243. Mov Disord. 2009. PMID: 19224590 Clinical Trial.
-
Subjective visual vertical may be altered by bilateral subthalamic deep brain stimulation.Mov Disord. 2009 Jul 30;24(10):1556-7. doi: 10.1002/mds.22605. Mov Disord. 2009. PMID: 19425082 No abstract available.
-
[Deep brain stimulation for Parkinson's disease].No To Shinkei. 2004 Oct;56(10):827-41. No To Shinkei. 2004. PMID: 15609670 Review. Japanese. No abstract available.
Cited by
-
Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson's disease following deep brain stimulation.Front Neurosci. 2022 Sep 14;16:948523. doi: 10.3389/fnins.2022.948523. eCollection 2022. Front Neurosci. 2022. PMID: 36188463 Free PMC article.
-
Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial.J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):164-70. doi: 10.1136/jnnp-2011-300008. Epub 2011 Sep 2. J Neurol Neurosurg Psychiatry. 2012. PMID: 21890575 Free PMC article. Clinical Trial.
-
Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors.Neurosurg Rev. 2025 Jan 23;48(1):73. doi: 10.1007/s10143-025-03206-9. Neurosurg Rev. 2025. PMID: 39843798
-
Critical aspects of clinical trial design for novel cell and gene therapies.Parkinsons Dis. 2011;2011:804041. doi: 10.4061/2011/804041. Epub 2011 Dec 27. Parkinsons Dis. 2011. PMID: 22254150 Free PMC article.
-
Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets.Expert Rev Neurother. 2010 Dec;10(12):1847-57. doi: 10.1586/ern.10.156. Expert Rev Neurother. 2010. PMID: 21384698 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical